[[reporting]]
== Reporting standards

[[sec-reporting-guidelines]]
=== Reporting guidelines

Clinical studies of phytomedicines shall be reported in accordance with
recognized reporting guidelines:

* CONSORT for randomized controlled trials
* STROBE for observational studies
* PRISMA for systematic reviews
* TREND for non-randomized evaluations

[[sec-reporting-elements]]
=== Essential reporting elements

Reports of phytomedicine clinical studies shall include:

==== Product information

* Complete botanical identification (species, authority, plant part)
* Extract type and method of preparation
* Drug-to-extract ratio (for extracts)
* Standardization information (marker compounds and levels)
* Dose and dosing regimen
* Manufacturer and batch numbers

==== Study methods

* Study design and justification
* Participant eligibility criteria
* Interventions for each group
* Outcome measures and timing
* Sample size calculation
* Randomization and blinding methods
* Statistical methods

==== Results

* Participant flow (recruitment, allocation, follow-up, analysis)
* Baseline characteristics
* Results for primary and secondary outcomes
* Harms and adverse events
* Limitations

[[sec-data-sharing]]
=== Data sharing

To support evidence synthesis and transparency:

* Individual participant data should be made available where possible
* Study protocols and statistical analysis plans should be published
* Negative and inconclusive results should be reported
